Table 1.
Strain | Serotype a | MLST b | Year of isolation | Isolation site c | Underlying conditions c | Clinical manifestation d | Gender | Age | Geographical location of isolation e | Reference |
---|---|---|---|---|---|---|---|---|---|---|
Laboratory strains | ||||||||||
MinnA | b | n/a | 1979 | CSF | n/a | Septic shock | n/a | Child | Minneapolis, USA | [16] |
3655 | Nontypeable | n/a | n/a | Middle ear | n/a | AOM | n/a | Child | Missouri, USA | [17] |
Clinical isolates | ||||||||||
KR494 | f | 124 | 2008 | Blood | Healthy | Septic shock | Male | 70 | Skåne | [9] |
G19 | f | 124 | 2008 | Blood | n/a | n/a | Male | 57 | Gothenburg | [3] |
G20 | f | 124 | 2008 | Blood | n/a | n/a | Male | 4 | Gothenburg | [3] |
K238 | f | 124 | 2007 | Blood | n/a | n/a | Female | 63 | Stockholm | [3] |
L11 | f | n/a | 2006 | Blood | MDS | Bacteremia/sepsis | Male | 65 | Skåne | [3] |
L16 | f | n/a | 2007 | CSF | Healthy | Bacteremia/sepsis | Male | 74 | Skåne | [3] |
L21 | f | 124 | 2008 | Blood | Healthy | Septic shock | Male | 82 | Skåne | [3] |
L22 | f | 124 | 2008 | Blood | Severe COPD | Bacteremia/sepsis | Male | 81 | Skåne | [3] |
L24 | f | 124 | 2009 | Blood | Healthy | Bacteremia/sepsis | Male | 65 | Skåne | [3] |
L25 | f | 124 | 2009 | Blood | Healthy | Septic shock | Male | 51 | Skåne | [3] |
L29 | f | 124 | 2009 | Blood | Healthy | Septic shock | Male | 77 | Skåne | [3] |
L45 | f | n/a | 2005 | Blood | Healthy | Septic shock | Male | 51 | Skåne | [3] |
L50 | f | 124 | 2007 | Blood | Healthy | Septic shock | Male | 63 | Skåne | [3] |
L59 | f | n/a | 2007 | Blood | Healthy | Severe sepsis | Male | 71 | Skåne | [3] |
M1 | f | 124 | 2009 | Blood | leucemia | Bacteremia/sepsis | Male | 3 | Skåne | [3] |
M10 | f | 124 | 2008 | Blood | Solid tumor | Bacteremia/sepsis | Female | 77 | Skåne | [3] |
M14 | f | 124 | 2008 | Blood | Solid tumor | Bacteremia/sepsis | Male | 63 | Skåne | [3] |
M29 | f | n/a | 2006 | CSF | Healthy | Septic shock | Male | 0 | Skåne | [3] |
M54 | f | n/a | 1999 | Blood | Healthy | Bacteremia/sepsis | Female | 78 | Skåne | [3] |
S208 | f | 124 | 2008 | CSF | n/a | n/a | Female | 61 | Stockholm | [3] |
S229 | f | 124 | 2008 | Blood | n/a | n/a | Female | 88 | Stockholm | [3] |
aIsolates were characterized by standard bacteriological techniques as described [3]. Strain serotype was verified by PCR whereas H. haemolyticus was excluded by 16S rRNA typing [3].
bMultilocus sequence typing (MLST) was performed as previously described [18].
cCOPD, chronic obstructive pulmonary disease; CSF, cerebrospinal fluid; MDS, myelodysplastic syndrome.
dAOM, acute otitis media.
eClinical isolates were from three different geographical areas of Sweden: Stockholm, Gothenburg and Skåne spanning from the years 1999–2009, isolated from blood or cerebrospinal fluid (CSF), but the clinical presentation, which was known for 15 of the 20 cases of invasive disease, ranged from Septic shock and epiglottitis to mild disease [3].
n/a, data not available.